loratadine and transforming growth factor beta

loratadine has been researched along with transforming growth factor beta in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Alobid, I; Bernal-Sprekelsen, M; Mullol, J; Picado, C; Pujols, L; Roca-Ferrer, J; Valero, A; Xaubet, A	1
Bocheńska-Marciniak, M; Górski, P; Kuna, P; Kupczyk, M; Tworek, D	1
Badawi, AM; Elrehany, M; Maher, SA; Mansour, HF; Mohamad, SA; Safwat, MA	1

Trials

1 trial(s) available for loratadine and transforming growth factor beta

Article	Year
The effect of 4 weeks treatment with desloratadine (5mg daily) on levels of interleukin (IL)-4, IL-10, IL-18 and TGF beta in patients suffering from seasonal allergic rhinitis. Pulmonary pharmacology & therapeutics, 2007, Volume: 20, Issue:3 Topics: Adult; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Interleukin-10; Interleukin-18; Interleukin-4; Interleukins; Loratadine; Male; Recurrence; Rhinitis, Allergic, Seasonal; Sleep Wake Disorders; Time Factors; Transforming Growth Factor beta; Treatment Outcome	2007

Article

Year

The effect of 4 weeks treatment with desloratadine (5mg daily) on levels of interleukin (IL)-4, IL-10, IL-18 and TGF beta in patients suffering from seasonal allergic rhinitis.

Pulmonary pharmacology & therapeutics, 2007, Volume: 20, Issue:3

Topics: Adult; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Interleukin-10; Interleukin-18; Interleukin-4; Interleukins; Loratadine; Male; Recurrence; Rhinitis, Allergic, Seasonal; Sleep Wake Disorders; Time Factors; Transforming Growth Factor beta; Treatment Outcome

2007

Other Studies

2 other study(ies) available for loratadine and transforming growth factor beta

Article	Year
Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2006, Volume: 36, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Cell Survival; Cells, Cultured; Chemokine CCL11; Chemokine CCL5; Chemokines, CC; Enzyme-Linked Immunosorbent Assay; Eosinophils; Epithelial Cells; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Histamine H1 Antagonists; Humans; Interleukin-5; Interleukin-6; Interleukin-8; Loratadine; Male; Middle Aged; Nasal Mucosa; Nasal Polyps; Statistics, Nonparametric; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A	2006
A novel nasal co-loaded loratadine and sulpiride nanoemulsion with improved downregulation of TNF-α, TGF-β and IL-1 in rabbit models of ovalbumin-induced allergic rhinitis. Drug delivery, 2021, Volume: 28, Issue:1 Topics: Administration, Intranasal; Animals; Calorimetry, Differential Scanning; Disease Models, Animal; Dopamine Antagonists; Drug Combinations; Drug Liberation; Emulsions; Glycerol; Glycine max; Histamine H1 Antagonists, Non-Sedating; In Vitro Techniques; Interleukin-1; Lecithins; Loratadine; Nanostructures; Nasal Mucosa; Olive Oil; Ovalbumin; Paranasal Sinuses; Polysorbates; Rabbits; Rhinitis, Allergic; Sodium Cholate; Spectroscopy, Fourier Transform Infrared; Sulpiride; Surface-Active Agents; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha	2021

Article

Year

Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2006, Volume: 36, Issue:1

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Cell Survival; Cells, Cultured; Chemokine CCL11; Chemokine CCL5; Chemokines, CC; Enzyme-Linked Immunosorbent Assay; Eosinophils; Epithelial Cells; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Histamine H1 Antagonists; Humans; Interleukin-5; Interleukin-6; Interleukin-8; Loratadine; Male; Middle Aged; Nasal Mucosa; Nasal Polyps; Statistics, Nonparametric; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A

2006

A novel nasal co-loaded loratadine and sulpiride nanoemulsion with improved downregulation of TNF-α, TGF-β and IL-1 in rabbit models of ovalbumin-induced allergic rhinitis.

Drug delivery, 2021, Volume: 28, Issue:1

Topics: Administration, Intranasal; Animals; Calorimetry, Differential Scanning; Disease Models, Animal; Dopamine Antagonists; Drug Combinations; Drug Liberation; Emulsions; Glycerol; Glycine max; Histamine H1 Antagonists, Non-Sedating; In Vitro Techniques; Interleukin-1; Lecithins; Loratadine; Nanostructures; Nasal Mucosa; Olive Oil; Ovalbumin; Paranasal Sinuses; Polysorbates; Rabbits; Rhinitis, Allergic; Sodium Cholate; Spectroscopy, Fourier Transform Infrared; Sulpiride; Surface-Active Agents; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha

2021